Patent application number | Description | Published |
20080242648 | COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER - The present embodiments relate to compositions and methods of treatment of cancer. More particularly, the present embodiments relate to the combination of an ERĪ±+ ligand with an HDACi for the treatment of cancer, methods of treating cancer and pharmaceutical compositions for treating cancer. | 10-02-2008 |
20090149511 | Administration of an Inhibitor of HDAC and an mTOR Inhibitor - Methods of treating patients with an HDAC inhibitor and an mTOR inhibitor are provided. | 06-11-2009 |
20100267779 | Novel Compounds and Methods of Using Them - Described herein are novel HDAC inhibitors, formulations containing them and methods of using them. In some embodiments, the HDAC inhibitors possess specific stereochemistry. In other embodiments, the compounds described herein are used in the treatment or prevention of histone deacetylase mediated disorders. | 10-21-2010 |
20100298270 | Novel Compounds and Methods of Using Them - Described herein are novel HDAC modulators, formulations containing them and methods of using them. In some embodiments, the HDAC modulators possess specific stereo chemistry. In other embodiments, the compounds described herein are used in the treatment or prevention of histone deacetylase mediated disorders. | 11-25-2010 |
20100305167 | Administration of an Inhibitor of HDAC - Methods of treating patients with SNDX-275 are provided. | 12-02-2010 |
20110182888 | Administration of an Inhibitor of HDAC, an Inhibitor of HER-2, and a Selective Estrogen Receptor Modulator - Methods of treating patients with an HDAC inhibitor and a HER-2 inhibitor are provided herein. In some embodiments, a SERM is also administered. | 07-28-2011 |
20130150386 | METHODS FOR THE TREATMENT OF LUNG CANCER - Described herein are methods for the treatment of lung cancer in a subject. In particular, methods are provided for the treatment of resistant lung cancer with a combination of entinostat and an EGFR inhibitor. | 06-13-2013 |
20130303575 | ADMINISTRATION OF AN INHIBITOR OF HDAC - Methods of treating patients with SNDX-275 are provided. | 11-14-2013 |
20140378420 | METHODS FOR THE TREATMENT OF BREAST CANCER - Described herein are methods for the treatment of breast cancer in a subject. In particular, methods are provided for the treatment of resistant, metastatic breast cancer with a combination of entinostat and an aromatase inhibitor. | 12-25-2014 |